OAM
PACB icon

Oxford Asset Management’s Pacific Biosciences PACB Stock Holding History

Oxford Asset Management’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-21,451
Closed -$80.4K – 388
2024
Q1 		$80.4K Buy
+21,451
New +$126K 0.08% 234
2019
Q3 		– Sell
-249,530
Closed -$1.51M – 1893
2019
Q2 		$1.51M Sell
249,530
-647,993
-72% -$4.54M 0.03% 777
2019
Q1 		$6.49M Buy
897,523
+250,000
+39% +$1.81M 0.14% 166
2018
Q4 		$4.79M Buy
647,523
+569,253
+727% +$3.61M 0.12% 184
2018
Q3 		$434K Buy
+78,270
New +$336K 0.01% 1358
2016
Q3 		– Sell
-31,630
Closed -$223K – 829
2016
Q2 		$223K Sell
31,630
-228,502
-88% -$2.09M 0.01% 679
2016
Q1 		$2.21M Buy
260,132
+100,560
+63% +$989K 0.06% 354
2015
Q4 		$2.19M Buy
+159,572
New +$1.43M 0.05% 376
2015
Q3 		– Sell
-256,891
Closed -$1.48M – 701
2015
Q2 		$1.48M Sell
256,891
-46,091
-15% -$267K 0.04% 388
2015
Q1 		$1.77M Buy
+302,982
New +$2.09M 0.05% 385
2014
Q3 		– Sell
-162,095
Closed -$1M – 734
2014
Q2 		$1M Sell
162,095
-421,522
-72% -$2.11M 0.03% 487
2014
Q1 		$3.12M Buy
+583,617
New +$3.69M 0.09% 289

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
MA
Madrone Advisors Menlo Park, California $1.03B AUM 20.53% 1-Year Est. Return
EDRH
Edmond de Rothschild Holding Chambesy, Switzerland $6.91B AUM 19.7% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Oxford Asset Management's PACB Position: Q2 2024 in Review

Oxford Asset Management sold out of Pacific Biosciences (PACB) in Q2 2024, closing a stake of 21,451 shares — an estimated $80.4K sold.

Oxford Asset Management first reported a position in PACB in Q1 2014 and held it in 12 quarters. The position peaked at $6.49M in Q1 2019. 228 funds tracked by Wall St. Rank hold PACB as of Q2 2024.

  • Oxford Asset Management reported no remaining Pacific Biosciences position as of Q2 2024 after selling out during the quarter.
  • Oxford Asset Management sold 21,451 Pacific Biosciences shares in Q2 2024, an estimated $80.4K.
  • Oxford Asset Management first reported a position in Pacific Biosciences in Q1 2014 and held it in 12 quarters.
  • Oxford Asset Management's Pacific Biosciences position peaked at $6.49M in Q1 2019.
  • 228 funds tracked by Wall St. Rank held Pacific Biosciences as of Q2 2024.

Based on Oxford Asset Management's 13F filing for Q2 2024, filed 14 Aug 2024.